Cargando…
Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282758/ https://www.ncbi.nlm.nih.gov/pubmed/35843259 http://dx.doi.org/10.1016/S1473-3099(22)00430-3 |
| _version_ | 1784747177383297024 |
|---|---|
| author | Sun, Fangfang Lin, Yanwei Wang, Xiaodong Gao, Yuan Ye, Shuang |
| author_facet | Sun, Fangfang Lin, Yanwei Wang, Xiaodong Gao, Yuan Ye, Shuang |
| author_sort | Sun, Fangfang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9282758 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92827582022-07-15 Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection Sun, Fangfang Lin, Yanwei Wang, Xiaodong Gao, Yuan Ye, Shuang Lancet Infect Dis Correspondence Elsevier Ltd. 2022-09 2022-07-14 /pmc/articles/PMC9282758/ /pubmed/35843259 http://dx.doi.org/10.1016/S1473-3099(22)00430-3 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Sun, Fangfang Lin, Yanwei Wang, Xiaodong Gao, Yuan Ye, Shuang Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection |
| title | Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection |
| title_full | Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection |
| title_fullStr | Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection |
| title_full_unstemmed | Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection |
| title_short | Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection |
| title_sort | paxlovid in patients who are immunocompromised and hospitalised with sars-cov-2 infection |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282758/ https://www.ncbi.nlm.nih.gov/pubmed/35843259 http://dx.doi.org/10.1016/S1473-3099(22)00430-3 |
| work_keys_str_mv | AT sunfangfang paxlovidinpatientswhoareimmunocompromisedandhospitalisedwithsarscov2infection AT linyanwei paxlovidinpatientswhoareimmunocompromisedandhospitalisedwithsarscov2infection AT wangxiaodong paxlovidinpatientswhoareimmunocompromisedandhospitalisedwithsarscov2infection AT gaoyuan paxlovidinpatientswhoareimmunocompromisedandhospitalisedwithsarscov2infection AT yeshuang paxlovidinpatientswhoareimmunocompromisedandhospitalisedwithsarscov2infection |